Investor Dossier
EQT Life Sciences
active
Typeinvestor
Location—
Portfolio (5 investments)
Amolyt Pharma
Series B · Sept 2021
€68.0M
DNA Script
Series C · Oct 2021
€140.3M
Egle Therapeutics
Series A · Oct 2021
€40.0M
ImCheck Therapeutics
Series C · Jun 2022
€96.0M
Amolyt Pharma
Series C · Jan 2023
€128.1M